Baebies Completes First Close on Series B Financing

DURHAM, N.C., February 27, 2017 – Baebies, Inc., a company focused on advancing newborn screening and pediatric testing, announced today it has completed a $5 million first close on its Series B financing. The company plans to raise an additional $5 million in the coming months. Baebies received clearance from the U.S. Food and Drug Administration (FDA) for its SEEKER newborn screening system earlier this month.

“Our FDA clearance creates an opportunity to take the company to the next level. We have a great product and a great team, and this Series B will ensure that we have the financial resources required to complete the journey to commercialization,” said Richard West, Baebies’ CEO.

About Baebies, Inc.
At Baebies our sole focus is to advance newborn screening and other pediatric testing worldwide. Baebies is guided by the vision that “everyone deserves a healthy start”. Baebies is developing innovative, easy to use and connected products to make life better for millions of babies. By bringing new technologies and new tests to the healthcare community, Baebies is providing hope to parents and the chance at a better life to newborns. For more information, please visit

Press Contact
Jeff Florence

Help spread the word!